NCT01088828

Brief Summary

The purpose of this study is to:

  1. 1.compare structural variations observed in the calf and foot of the clubfoot mouse model(pma)with human clubfoot patients antenatally and postnatally;
  2. 2.identify features that might be used in future large scale studies to delineate a subtype of human clubfoot associated with lack of response to standard 'Ponseti' manipulation treatments.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2010

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 17, 2010

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2010

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2011

Completed
Last Updated

November 5, 2015

Status Verified

November 1, 2015

Enrollment Period

1 year

First QC Date

March 16, 2010

Last Update Submit

November 4, 2015

Conditions

Keywords

MRI, clubfoot, CTEV, Congenital Talipes Equinovarus

Study Arms (5)

Group A

Foetuses with clubfoot identified in utero (n=15). Of these: * around 10 will be born with clubfoot and will form most of Group B, * around 5 will be born without clubfoot and will form part of group C.

Other: Magnetic Resonance Imaging (MRI) of calf and foot

Group B

Neonates affected by clubfoot (n=10)

Other: Magnetic Resonance Imaging (MRI) of calf and foot

Group C

Control group of unaffected neonates (n=10)

Other: Magnetic Resonance Imaging (MRI) of calf and foot

Group D

Young adults having completed treatment (n=5)

Other: Magnetic Resonance Imaging (MRI) of calf and foot

Group E

Control group of young unaffected adults (n=5)

Other: Magnetic Resonance Imaging (MRI) of calf and foot

Interventions

Detailed 3-D comparison of MRI scans of children with clubfoot and controls without clubfoot in utero, in untreated infants and in older children who have been treated.

Also known as: MR scan
Group AGroup BGroup CGroup DGroup E

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Group A: Pregnant women carrying a foetus with suspected clubfoot. Group B: Neonates affected by clubfoot Group C: Unaffected neonates Group D: Young adults who have undergone treatment for clubfoot Group E: Control group of young unaffected adults

You may qualify if:

  • Group A - pregnancies suspected to be affected by clubfoot on detailed scan. Group B - neonates / infants with clubfoot. Age Preferably under 3 months). Group C - neonates / infants without clubfoot.Preferably under 3 months). Group D- young adults who have undergone treatment for clubfoot and are not undergoing further active treatment. Age range 14-30 years.
  • Group E - young adults without known lower limb pathology. Age 14-30 years.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Aberdeen

Aberdeen, AB24 3FX, United Kingdom

Location

MeSH Terms

Conditions

Clubfoot

Interventions

Magnetic Resonance Spectroscopy

Condition Hierarchy (Ancestors)

TalipesFoot Deformities, AcquiredFoot DeformitiesMusculoskeletal DiseasesFoot Deformities, CongenitalLower Extremity Deformities, CongenitalLimb Deformities, CongenitalMusculoskeletal AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Spectrum AnalysisChemistry Techniques, AnalyticalInvestigative Techniques

Study Officials

  • Zosia H Miedzybrodzka, MBChB, PhD

    University of Aberdeen

    PRINCIPAL INVESTIGATOR
  • Simon L Barker, FRCS, MD

    NHS Grampian Health Board

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 16, 2010

First Posted

March 17, 2010

Study Start

May 1, 2010

Primary Completion

May 1, 2011

Study Completion

May 1, 2011

Last Updated

November 5, 2015

Record last verified: 2015-11

Locations